ISODIOL INTERNATIONAL INC. CORPORATE UPDATE
04 Agosto 2017 - 7:00AM
InvestorsHub NewsWire
ISODIOL INTERNATIONAL INC. CORPORATE UPDATE
August 04, 2017 -- Vancouver, BC -- InvestorsHub NewsWire --
Isodiol International Inc. (CSE:
ISOL) (OTC:
ISOLF) (Frankfurt: LB6A.F)
(the "Company" or "Isodiol") a global cannabis innovator
specializing in the development of pharmaceutical and consumer
products announces unaudited July 2017 revenue numbers of its
wholly owned subsidiary ISO International LLC of $1,358,787
USD.
Marcos Agramont CEO of Isodiol stated, "We have demonstrated
another strong month of top line revenues in what typically is a
slow period of the year. Our sales and marketing teams have done an
incredible job developing distributor and customer relationships
which provide the Company with re-occurring monthly business. In an
ultra-competitive industry that is continuously evolving, we
continue to establish ourselves as leaders in product quality and
service. The Company continues to develop and gain penetration with
its Pharmaceutical grade products in Latin America and remains
committed to increasing its top line revenues and ultimately
increasing its profitability. We continue to develop our
infrastructure in Latin America and will begin the due diligence
process of expanding into the European and Asian markets in the
near future."
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in
pharmaceutical grade cannabis compounds and the industry leader in
manufacturing and development of consumer products. Isodiol's
nutraceutical division is the pioneer of many firsts for
Hemp-derived Cannabinoids, including 99% pure crystalline isolate,
micro-encapsulation, and nano technology for the highest quality
consumable and topical skin care products.
Isodiol's growth strategy includes the development of
over-the-counter and pharmaceutical drugs, seeking joint
ventures and acquisitions to expand its portfolio of brands and
subsidiaries and will aggressively continue International expansion
into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD: "Marcos Agramont" CEO &
Director
CORPORATE MEDIA: ir@isodiol.com www.isodiol.com
Join Us On Face Book: https://www.facebook.com/isodiol/
Twitter: @isodiol
Forward-Looking Information: This news release contains
"forward-looking information" within the meaning of applicable
securities laws relating to statements regarding the Company's
business, products and future the Companys business, its product
offerings and plans for sales and marketing. Although the Company
believes that the expectations reflected in the forward looking
information are reasonable, there can be no assurance that such
expectations will prove to be correct. Readers are cautioned to not
place undue reliance on forward-looking information. Such forward
looking statements are subject to risks and uncertainties that may
cause actual results, performance and developments to differ
materially from those contemplated by these statements depending
on, among other things, the risks that the Company's products and
plan will vary from those stated in this news release and the
Company may not be able to carry out its business plans as
expected. Except as required by law, the Company expressly
disclaims any obligation, and does not intend, to update any
forward looking statements or forward-looking information in this
news release. Although the Company believes that the expectations
reflected in the forward looking information are reasonable, there
can be no assurance that such expectations will prove to be correct
and makes no reference to profitability based on sales reported.
The statements in this news release are made as of the date of this
release.
The CSE has not reviewed, approved or disapproved the content of
this press release.
Isodiol (CSE:ISOL)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Isodiol (CSE:ISOL)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024